Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck & Co., Inc. Pushing The Throttle On Oncology
Motley Fool
Friday, February 7, 2014 - 10:29am
tags:
Merck, oncology, cancer, MK-3475
Biogen Idec Inc.: Tecfidera Continues Its Blistering Pace
Motley Fool
Friday, February 7, 2014 - 9:47am
tags:
Tecfidera, Biogen Idec, MS, multiple sclerosis
A Way To Increase Drug R&D Success Rates
Forbes
Friday, February 7, 2014 - 9:46am
tags:
R&D, Accelerating Medicines Partnership
New Study Provides Good News For Intuitive Surgical
Forbes
Friday, February 7, 2014 - 9:44am
tags:
Intuitive Surgical, hysterectomies, Da Vinci Surgical System, devices
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Friday, February 7, 2014 - 9:43am
tags:
Array Biopharma, Biodel, Galena Biopharma, Novavax, Protalix BioTherapeutics, Rigel Pharmaceuticals, Synta Pharmaceuticals, Zogenix
Roche wins battle against India sales of generic cancer drug
FT.com
Friday, February 7, 2014 - 9:40am
tags:
Roche, India, breast cancer, biosimilars, Biocon, Mylan
Bristol-Myers Has A Bright Future Outlook
Seeking Alpha
Friday, February 7, 2014 - 9:39am
tags:
Bristol-Myers Squibb, earnings
Shire scraps Vyvanse for depression after failed trials
Yahoo/Reuters
Friday, February 7, 2014 - 9:37am
tags:
Shire, Vyvanse, ADHD, clinical depression
IPO Preview: Argos Therapeutics
Seeking Alpha
Friday, February 7, 2014 - 9:30am
tags:
IPOs, Argos Therapeutics, AGS-003, renal cell carcinoma
IPO Preview: NephroGenex
Seeking Alpha
Friday, February 7, 2014 - 9:28am
tags:
IPOs, NephroGenex, kidney disease
Neurocrine Biosciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript
Seeking Alpha
Friday, February 7, 2014 - 9:24am
tags:
Neurocrine Biosciences, earnings
AstraZeneca Boasts of Pipeline as Analysts See Deal Ahead
Bloomberg
Friday, February 7, 2014 - 9:22am
tags:
AstraZeneca, roxadustat, kidney disease, non-small cell lung cancer, AZD9291
Merck Said to Agree to $100 Million NuvaRing Settlement
Bloomberg
Thursday, February 6, 2014 - 6:13pm
tags:
Merck, Nuvaring
Medicines Co. Awarded BARDA Contract
Yahoo/Zacks.com
Thursday, February 6, 2014 - 6:12pm
tags:
BARDA, The Medicines Company, Carbavance
Novo Nordisk Gives anti-NKG2A Rights to Innate
Yahoo/Zacks.com
Thursday, February 6, 2014 - 6:09pm
tags:
Innate Pharma S.A., Novo Nordisk, anti-NKG2A
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Yahoo/Reuters
Thursday, February 6, 2014 - 6:08pm
tags:
Spectrum Pharmaceuticals, FDA, Beleodaq, T-cell lymphoma
2014: End of the Road for the American Rx Salesperson?
Pharm Exec
Thursday, February 6, 2014 - 12:02pm
tags:
drug reps, layoffs
Merck's New Drugs Are Bringing New Hope
Seeking Alpha
Thursday, February 6, 2014 - 11:59am
tags:
Merck, Januvia, China, India, MK-3475
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Bloomberg
Thursday, February 6, 2014 - 10:18am
tags:
Circassia, IPOs, vaccines, allergies
AstraZeneca takes on Merck in Alzheimer's drug race
Yahoo/Reuters
Thursday, February 6, 2014 - 9:57am
tags:
AstraZeneca, Merck, Alzheimer's disease, AZD3293, BACE inhibitors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.